Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
Cannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady
大麻股票對緝毒局改期的反應：Canopy & Aurora Surge、Tilray、WM Tech保持穩定
In a historic trading session on Tuesday, cannabis stocks soared following the DEA's decision to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
在週二的歷史性交易時段中，在緝毒局決定根據《管制物質法》將大麻從附表一重新歸類爲附表三之後，大麻股票飆升。
This regulatory shift aligning with a recommendation from the Department of Health and Human Services, sparked investor interest
這種監管轉變符合衛生與公共服務部的建議，激發了投資者的興趣
evidenced by gains in major cannabis stocks on the NASDAQ.
納斯達克主要大麻股票的漲勢就證明了這一點。
Canopy Growth Corporation (NASDAQ:CGC) led the gains, skyrocketing by 78.8% to close at $14.88 per share amid a trading frenzy that pushed the volume to 79.25 million shares.
Canopy Growth Corporation（納斯達克股票代碼：CGC）領漲，飆升78.8％，收於每股14.88美元，交易狂潮將成交量推高至7,925萬股。
Aurora Cannabis (NASDAQ:ACB) wasn't far behind, climbing 46.0% to close at $9.23 per share with a volume...
Aurora Cannabis（納...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。